APO Research
Talk to an analyst

APO RESEARCH · REPORT

Amphetamine Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Amphetamine Drug Market Outlook and Growth Opportunities 2026

2 January 2026192 pages

Choose your research edition.

Industry ResearchAmphetamine Drug Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Amphetamine Drug Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Amphetamine Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amphetamine Drug Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Amphetamine Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Amphetamine Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Amphetamine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Amphetamine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Amphetamine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Amphetamine Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Amphetamine Drug market include Novartis, Eli Lilly, Pfizer, GSK, Purdue Pharma and Hisamitsu Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Amphetamine Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Amphetamine Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Amphetamine Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Amphetamine Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Amphetamine Drug Segment by Company

Novartis

Eli Lilly

Pfizer

GSK

Purdue Pharma

Hisamitsu Pharmaceutical

Amphetamine Drug Segment by Type

Adult

Children

Amphetamine Drug Segment by Application

Retail Pharmacy

Hospital Pharmacy

Other

Amphetamine Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Amphetamine Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Amphetamine Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Amphetamine Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Amphetamine Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amphetamine Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amphetamine Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amphetamine Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Amphetamine Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Amphetamine Drug industry.

Chapter 3: Detailed analysis of Amphetamine Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Amphetamine Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Amphetamine Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Amphetamine Drug Industry Trends Table 2. Amphetamine Drug Industry Drivers Table 3. Amphetamine Drug Industry Opportunities and Challenges Table 4. Amphetamine Drug Industry Restraints Table 5. Global Amphetamine Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Amphetamine Drug Revenue Share by Company (2021-2026) Table 7. Global Amphetamine Drug Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Amphetamine Drug Sales Volume Share by Company (2021-2026) Table 9. Global Amphetamine Drug Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Amphetamine Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Amphetamine Drug Key Company Manufacturing Base & Headquarters Table 12. Global Amphetamine Drug Company, Product Type & Application Table 13. Global Amphetamine Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Amphetamine Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Adult Table 18. Significant Companies of Children Table 19. Global Amphetamine Drug Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Amphetamine Drug Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Amphetamine Drug Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Amphetamine Drug Sales Volume Share by Type (2021-2026) Table 23. Global Amphetamine Drug Sales Volume Share by Type (2027-2032) Table 24. Global Amphetamine Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Amphetamine Drug Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Amphetamine Drug Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Amphetamine Drug Sales Value Share by Type (2021-2026) Table 28. Global Amphetamine Drug Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Retail Pharmacy Table 30. Significant Companies of Hospital Pharmacy Table 31. Significant Companies of Other Table 32. Global Amphetamine Drug Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Amphetamine Drug Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Amphetamine Drug Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Amphetamine Drug Sales Volume Share by Application (2021-2026) Table 36. Global Amphetamine Drug Sales Volume Share by Application (2027-2032) Table 37. Global Amphetamine Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Amphetamine Drug Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Amphetamine Drug Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Amphetamine Drug Sales Value Share by Application (2021-2026) Table 41. Global Amphetamine Drug Sales Value Share by Application (2027-2032) Table 42. Global Amphetamine Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Amphetamine Drug Sales by Region (2021-2026) & (K Units) Table 44. Global Amphetamine Drug Sales Market Share by Region (2021-2026) Table 45. Global Amphetamine Drug Sales by Region (2027-2032) & (K Units) Table 46. Global Amphetamine Drug Sales Market Share by Region (2027-2032) Table 47. Global Amphetamine Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Amphetamine Drug Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Amphetamine Drug Sales Value Share by Region (2021-2026) Table 50. Global Amphetamine Drug Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Amphetamine Drug Sales Value Share by Region (2027-2032) Table 52. Global Amphetamine Drug Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Amphetamine Drug Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Amphetamine Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Amphetamine Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Amphetamine Drug Sales by Country (2021-2026) & (K Units) Table 57. Global Amphetamine Drug Sales Market Share by Country (2021-2026) Table 58. Global Amphetamine Drug Sales by Country (2027-2032) & (K Units) Table 59. Global Amphetamine Drug Sales Market Share by Country (2027-2032) Table 60. Global Amphetamine Drug Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Amphetamine Drug Sales Value Market Share by Country (2021-2026) Table 62. Global Amphetamine Drug Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Amphetamine Drug Sales Value Market Share by Country (2027-2032) Table 64. Novartis Company Information Table 65. Novartis Business Overview Table 66. Novartis Amphetamine Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Novartis Amphetamine Drug Product Portfolio Table 68. Novartis Recent Development Table 69. Eli Lilly Company Information Table 70. Eli Lilly Business Overview Table 71. Eli Lilly Amphetamine Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Eli Lilly Amphetamine Drug Product Portfolio Table 73. Eli Lilly Recent Development Table 74. Pfizer Company Information Table 75. Pfizer Business Overview Table 76. Pfizer Amphetamine Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Pfizer Amphetamine Drug Product Portfolio Table 78. Pfizer Recent Development Table 79. GSK Company Information Table 80. GSK Business Overview Table 81. GSK Amphetamine Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. GSK Amphetamine Drug Product Portfolio Table 83. GSK Recent Development Table 84. Purdue Pharma Company Information Table 85. Purdue Pharma Business Overview Table 86. Purdue Pharma Amphetamine Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Purdue Pharma Amphetamine Drug Product Portfolio Table 88. Purdue Pharma Recent Development Table 89. Hisamitsu Pharmaceutical Company Information Table 90. Hisamitsu Pharmaceutical Business Overview Table 91. Hisamitsu Pharmaceutical Amphetamine Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Hisamitsu Pharmaceutical Amphetamine Drug Product Portfolio Table 93. Hisamitsu Pharmaceutical Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Amphetamine Drug Distributors List Table 97. Amphetamine Drug Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Amphetamine Drug Product Image Figure 2. Global Amphetamine Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Amphetamine Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Amphetamine Drug Sales (2021-2032) & (K Units) Figure 5. Global Amphetamine Drug Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Amphetamine Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Adult Image Figure 10. Children Image Figure 11. Global Amphetamine Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Amphetamine Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Amphetamine Drug Sales Volume Share by Type (2021-2032) Figure 14. Global Amphetamine Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Amphetamine Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Amphetamine Drug Sales Value Share by Type (2021-2032) Figure 17. Retail Pharmacy Image Figure 18. Hospital Pharmacy Image Figure 19. Other Image Figure 20. Global Amphetamine Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Amphetamine Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Amphetamine Drug Sales Volume Share by Application (2021-2032) Figure 23. Global Amphetamine Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Amphetamine Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Amphetamine Drug Sales Value Share by Application (2021-2032) Figure 26. Global Amphetamine Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Amphetamine Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Amphetamine Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Amphetamine Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Amphetamine Drug Sales Value (2021-2032) & (US$ Million) Figure 31. North America Amphetamine Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Amphetamine Drug Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Amphetamine Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Amphetamine Drug Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Amphetamine Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Amphetamine Drug Sales Value (2021-2032) & (US$ Million) Figure 37. South America Amphetamine Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Amphetamine Drug Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Amphetamine Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Amphetamine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Amphetamine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Amphetamine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Amphetamine Drug Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Amphetamine Drug Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Adult
  • Children
Applications
  • Retail Pharmacy
  • Hospital Pharmacy
  • Other
Companies covered
  • Novartis
  • Eli Lilly
  • Pfizer
  • GSK
  • Purdue Pharma
  • Hisamitsu Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Amphetamine Drug Sales Value (2021-2032)
  4. 1.2.2 Global Amphetamine Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Amphetamine Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Amphetamine Drug Market Dynamics
  1. 2.1 Amphetamine Drug Industry Trends
  2. 2.2 Amphetamine Drug Industry Drivers
  3. 2.3 Amphetamine Drug Industry Opportunities and Challenges
  4. 2.4 Amphetamine Drug Industry Restraints
3 Amphetamine Drug Market by Company
  1. 3.1 Global Amphetamine Drug Company Revenue Ranking in 2025
  2. 3.2 Global Amphetamine Drug Revenue by Company (2021-2026)
  3. 3.3 Global Amphetamine Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Amphetamine Drug Average Price by Company (2021-2026)
  5. 3.5 Global Amphetamine Drug Company Ranking (2024-2026)
  6. 3.6 Global Amphetamine Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Amphetamine Drug Company Product Type and Application
  8. 3.8 Global Amphetamine Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Amphetamine Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Amphetamine Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Amphetamine Drug Market by Type
  1. 4.1 Amphetamine Drug Type Introduction
  2. 4.1.1 Adult
  3. 4.1.2 Children
  4. 4.2 Global Amphetamine Drug Sales Volume by Type
  5. 4.2.1 Global Amphetamine Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Amphetamine Drug Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Amphetamine Drug Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Amphetamine Drug Sales Value by Type
  9. 4.3.1 Global Amphetamine Drug Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Amphetamine Drug Sales Value by Type (2021-2032)
  11. 4.3.3 Global Amphetamine Drug Sales Value Share by Type (2021-2032)
5 Amphetamine Drug Market by Application
  1. 5.1 Amphetamine Drug Application Introduction
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Hospital Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Amphetamine Drug Sales Volume by Application
  6. 5.2.1 Global Amphetamine Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Amphetamine Drug Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Amphetamine Drug Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Amphetamine Drug Sales Value by Application
  10. 5.3.1 Global Amphetamine Drug Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Amphetamine Drug Sales Value by Application (2021-2032)
  12. 5.3.3 Global Amphetamine Drug Sales Value Share by Application (2021-2032)
6 Amphetamine Drug Regional Sales and Value Analysis
  1. 6.1 Global Amphetamine Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Amphetamine Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Amphetamine Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Amphetamine Drug Sales by Region (2027-2032)
  5. 6.3 Global Amphetamine Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Amphetamine Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Amphetamine Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Amphetamine Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Amphetamine Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Amphetamine Drug Sales Value (2021-2032)
  12. 6.6.2 North America Amphetamine Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Amphetamine Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Amphetamine Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Amphetamine Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Amphetamine Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Amphetamine Drug Sales Value (2021-2032)
  21. 6.9.2 South America Amphetamine Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Amphetamine Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Amphetamine Drug Sales Value Share by Country, 2025 VS 2032
7 Amphetamine Drug Country-level Sales and Value Analysis
  1. 7.1 Global Amphetamine Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Amphetamine Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Amphetamine Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Amphetamine Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Amphetamine Drug Sales by Country (2027-2032)
  6. 7.4 Global Amphetamine Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Amphetamine Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Amphetamine Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Amphetamine Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Amphetamine Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Amphetamine Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Amphetamine Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Amphetamine Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Amphetamine Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Amphetamine Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Amphetamine Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Amphetamine Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Amphetamine Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Amphetamine Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Amphetamine Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Amphetamine Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Amphetamine Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Amphetamine Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Amphetamine Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Amphetamine Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Amphetamine Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Amphetamine Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Amphetamine Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Amphetamine Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Amphetamine Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Amphetamine Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Amphetamine Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Amphetamine Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Amphetamine Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Amphetamine Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Amphetamine Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Amphetamine Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Amphetamine Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis Amphetamine Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novartis Amphetamine Drug Product Portfolio
  6. 8.1.5 Novartis Recent Developments
  7. 8.2 Eli Lilly
  8. 8.2.1 Eli Lilly Company Information
  9. 8.2.2 Eli Lilly Business Overview
  10. 8.2.3 Eli Lilly Amphetamine Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Eli Lilly Amphetamine Drug Product Portfolio
  12. 8.2.5 Eli Lilly Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Amphetamine Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Amphetamine Drug Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 GSK
  20. 8.4.1 GSK Company Information
  21. 8.4.2 GSK Business Overview
  22. 8.4.3 GSK Amphetamine Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 GSK Amphetamine Drug Product Portfolio
  24. 8.4.5 GSK Recent Developments
  25. 8.5 Purdue Pharma
  26. 8.5.1 Purdue Pharma Company Information
  27. 8.5.2 Purdue Pharma Business Overview
  28. 8.5.3 Purdue Pharma Amphetamine Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Purdue Pharma Amphetamine Drug Product Portfolio
  30. 8.5.5 Purdue Pharma Recent Developments
  31. 8.6 Hisamitsu Pharmaceutical
  32. 8.6.1 Hisamitsu Pharmaceutical Company Information
  33. 8.6.2 Hisamitsu Pharmaceutical Business Overview
  34. 8.6.3 Hisamitsu Pharmaceutical Amphetamine Drug Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hisamitsu Pharmaceutical Amphetamine Drug Product Portfolio
  36. 8.6.5 Hisamitsu Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Amphetamine Drug Value Chain Analysis
  2. 9.1.1 Amphetamine Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Amphetamine Drug Sales Mode & Process
  6. 9.2 Amphetamine Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Amphetamine Drug Distributors
  9. 9.2.3 Amphetamine Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst